View drug registration information details.


ItemsRegistration information
ID481
No481
Brand NameCYPRESS
IngredientsCYPROTERONE ACETATE PH.EUR 2 MG, ETHINYLESTRADIOL PH.EUR 0.035 MG
Dosage FormFILM COATED TABLET
Primary PackagingALU/PVDC
StorageSTORE BELOW 30C
Shelf Life2 YEARS
Pack SizeA BLISTERPACK OF 21 TABLETS
Dispensing CategoryPRESCRIPTION
ATC ClassificationG03HB01
Pharmaceutical ClassANTIANDROGEN
IndicationsTREATMENT OF MODERATE TO SEVERE ACNE RELATED TO ANDROGEN-SENSITIVITY (WITH OR WITHOUT SEBORRHOEA) AND/OR HIRSUTISM, IN WOMEN OF REPRODUCTIVE AGE. FOR THE TREATMENT OF ACNE, CYPRESS SHOULD ONLY BE USED AFTER THERAPY OR SYSTEMIC ANTIBIOTIC TREATMENTS HAVE FAILED
Contraindications
Side EffectsNAUSEA, ABDOMINAL PAIN, WEIGHT INCREASED, HEADACHE, DEPRESSED MOOD, MOOD ALTERED, BREAST PAIN, BREAST TENDERNESS
Unit Price
EDL No
DescriptionROUND, LIGHT PINK, BICONVEX, FILM COATED TABLET DEBOSED " T" ON ONE SIDE AND OTHER SIDE PLAIN
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerMYLAN LABORATORIES LIMITED
CountryINDIA
Import Registration NoG/28/1297
Import Registration Date2016-11-04
ActivityCERTIFICATE RELEASED
Applied Date2022-07-14
FDD Registration No01 I 5665/24
FDD Registration Date2024-01-26
Expiry Date2027-01-25

Back to drug list